Yahoo11 Ağustos 2026 11:53 TR24 gün önce
VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook
Medication company Viatris (NASDAQ:VTRS) announced better-than-expected revenue in Q2 CY2026, with sales up 4.9% year on year to $3.76 billion. The company expects the full year’s revenue to be around $14.75 billion, close to analysts’ estimates. Its non-GAAP profit of $0.69 per share was 15% above analysts’ consensus estimates.
Haberin Tamamı Kaynağında
Burada gördüğün özet, haber sağlayıcısından geliyor; metnin devamı yayıncının sitesinde — Yahoo
Haberde Geçen Şirketler
Benzer Haberler
The trading volume of these stocks is deviating from the norm in today's session.
ChartMill52 dakika önce
Sodexo : Monthly disclosure on share capital and voting rights August 31, 2026
Yahoo2 saat önce
ANF vs. TPR: Which Stock Is the Better Value Option?
Yahoo2 saat önce
Anthropic's IPO Push Just Got a $15 Billion Backstop
Yahoo2 saat önce
Why Is Circle Internet Group, Inc. (CRCL) Up 63.1% Since Last Earnings Report?
Yahoo2 saat önce